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Incorporated fish oil fatty acids prevent action potential 
shortening induced by circulating fish oil fatty acids
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Increased consumption of fatty fish, rich in omega-3-polyunsaturated fatty acids (ω3-PUFAs) 
reduces the severity and number of arrhythmias. Long-term ω3-PUFA-intake modulates the 
activity of several cardiac ion channels leading to cardiac action potential shortening. Circulating 
ω3-PUFAs in the bloodstream and incorporated ω3-PUFAs in the cardiac membrane have 
a different mechanism to shorten the action potential. It is, however, unknown whether 
circulating ω3-PUFAs in the bloodstream enhance or diminish the effects of incorporated 
ω3-PUFAs. In the present study, we address this issue. Rabbits were fed a diet rich in fish 
oil (ω3) or sunflower oil (ω9, as control) for 3 weeks. Ventricular myocytes were isolated by 
enzymatic dissociation and action potentials were measured using the perforated patch-
clamp technique in the absence and presence of acutely administered ω3-PUFAs. Plasma 
of ω3 fed rabbits contained more free eicosapentaenoic acid (EPA) and isolated myocytes 
of ω3 fed rabbits contained higher amounts of both EPA and docosahexaenoic acid (DHA) in 
their sarcolemma compared to control. In the absence of acutely administered fatty acids, 
ω3 myocytes had a shorter action potential with a more negative plateau than ω9 myocytes. 
In the ω9 myocytes, but not in the ω3 myocytes, acute administration of a mixture of 
EPA + DHA shortened the action potential significantly. From these data we conclude that 
incorporated ω3-PUFAs into the sarcolemma and acutely administered ω3 fatty acids do not 
have a cumulative effect on action potential duration and morphology. As a consequence, 
patients with a high cardiac ω3-PUFA status will probably not benefit from short term ω3 
supplementation as an antiarrhythmic therapy.
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both acutely administered and incorporated ω3 fatty acids shorten 
the action potential (Den Ruijter et al., 2006, 2007, 2008; Verkerk 
et al., 2006; Berecki et al., 2007). However, the ionic currents that 
are affected by incorporated ω3 fatty acids are different from those 
affected by acutely administered ω3 fatty acids. This suggests that 
an additive effect may result when both are present. In this study, 
we address the issue by measuring cardiac action potentials of 
isolated ventricular myocytes of rabbits fed a diet rich in fish oil 
(ω3) or sunflower oil (ω9) for 3 weeks. We superfused these myo-
cytes with a mixture of ω3-PUFAs EPA and DHA. We conclude 
that acutely administered ω3-PUFAs cannot potentiate the effect 




The investigation was approved by the local ethics committee and 
complied with the guiding principles of the Declaration of Helsinki. 
Male New Zealand White rabbits (4-months old) received a diet 
supplemented with either 2.5% fish oil or 2.5% high oleic sunflower 
oil as control, for 3 weeks (Verkerk et al., 2009).
After the feeding period, the animals were anesthetized by a 
combination of ketamine (intramuscular 100 mg) and xylazine 
(intramuscular 20 mg), heparinized (Heparine LEO 5000 IU), 
introduCtion
The American Heart Association recommends to consume two 
portions of fish weekly, especially of fish rich in omega-3 poly-
unsaturated fatty acids (ω3-PUFAs) (Kris-Etherton et al., 2002). 
This advice is based on a large body of evidence that shows that 
increased intake of fish oil fatty acids has favorable effects on car-
diovascular disease outcomes (Burr et al., 1989; GISSI-Prevenzione 
Investigators, 1999; Yokoyama et al., 2007). A subanalysis of the 
GISSI Trial showed that an early and highly significant reduction 
of sudden cardiac death was the major component of total mor-
tality reduction (Marchioli et al., 2002). Ventricular arrhythmias 
often precede sudden death and the effect of fish oil on cardiac 
arrhythmias has been extensively studied in humans and animals 
(Billman et al., 1999; Schrepf et al., 2004). Acute administration 
of ω3-PUFAs as well as long-term fish oil feeding experiments 
have been repeatedly shown to reduce the severity and number of 
arrhythmias (for review, Den Ruijter et al., 2007).
The antiarrhythmic effect of the main circulating ω3-PUFAs 
(eicosapentaenoic acid, EPA and docosahexaenoic acid, DHA) is 
generally believed to be related to changes in cardiac cellular elec-
trophysiology (Leaf et al., 2002). Configuration and duration of 
the cardiac action potential is highly relevant for arrhythmogen-
esis, regardless whether reentry or triggered activity constitutes 
the underlying mechanism (Den Ruijter et al. 2007). In general, 
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Fatty aCid analysis
Lipids were extracted from left ventricular tissue were extracted as 
described previously (Folch et al., 1957). Phospholipids were iso-
lated with aminopropyl bonded phase columns (Bond Elut; Varian 
BV). Saponification and methylation of the phospholipids with 
boron trifluoride (Pierce, IL, USA) was performed and the formed 
fatty acid methyl esters were subjected to capillary gas chromatogra-
phy using a Chrompack column (Fused Silica, Chrompack), a flame 
ionization detector, and H
2
 as carrier gas. Fatty acid methyl esters 
were expressed as fraction of the total amount. Plasma free fatty 
acids were measured by gas-liquid chromatography (Püttmann 
et al., 1993).
statistiCs
Data are presented as mean ± SEM. Group comparisons were made 
using the (un)paired t-test. ANOVA was used where pertinent. 
P < 0.05 defines statistical significance.
results
Fish oil in CardiaC MeMbranes and plasMa
The 3-week diet rich in fish oil resulted in a significant increase of 
ω3 fatty acids EPA and DHA of in the total amount of fatty acids 
extracted from the heart in the fish oil ω3 group (Table 1). The total 
amount of mono-unsaturated fatty acids, however, was significantly 
lower in the fish oil ω3 group compared to the sunflower oil ω9 
group. Thus, ω3-PUFAs from the diet were incorporated in the 
cell membrane at the expense of mono-unsaturated fatty acids. 
In the plasma, free EPA levels were higher in the fish oil ω3 group 
compared to the sunflower oil ω9 group and the total amount of 
EPA + DHA was in the order of approximately 14 μmol/l. This 
amount is comparable to that measured in patients included in the 
study on omega-3 fatty acids and ventricular arrhythmia (SOFA) 
trial who were taking 2 g/day fish oil (Brouwer et al., 2006; Den 
Ruijter et al., 2008).
and killed by an injection of pentobarbital (240 mg). The hearts 
were quickly excised and left ventricular midmyocardial cells were 
isolated by enzymatic dissociation as described previously (Den 
Ruijter et al., 2008). In short, hearts were mounted on a Langendorff 
perfusion apparatus and retrogradely perfused through the aorta 
with the following solutions: (1) Tyrode’s solution for 15 min at a 
constant pressure (50 mm Hg), (2) a Ca2+-free Tyrode’s solution 
for 15 min (50 mm Hg), and (3) a Ca2+-free Tyrode’s solution to 
which collagenase type B (0.15 mg/ml, Boehringer Mannheim), 
collagenase type P (0.05 mg/ml, Boehringer Mannheim), trypsine 
inhibitor (0.1 mg/ml, Boehringer Mannheim), and 0.15 mg/ml 
hyaluronidase (Sigma, St. Louis, MO, USA) were added. During 
this last period, the ventricular free wall was perfused at a constant 
flow in a recirculating manner. When perfusion pressure dropped 
from an initial value of 50 to less than 2 mm Hg (usually after 
about 30 min), the left ventricular wall was cut into small pieces and 
further fractionated using a standard shaking protocol. All dissocia-
tion solutions were saturated with 100% O
2
 and the temperature 
was maintained at 37°C.
Small aliquots of cell suspension were put in a recording 
chamber on the stage of an inverted microscope. Cells were 
allowed to adhere for 5 min after which superfusion with solu-
tion was started. This extracellular solution (36 ± 0.2°C) con-





glucose 5.5, HEPES 5.0, pH 7.4 (NaOH). Quiescent rod-shaped 
myocytes with cross-striations and smooth surface were selected 
for measurements.
Throughout the manuscript N refers to the number of rabbits 
and n to the number of myocytes.
eleCtrophysiology
Action potentials were recorded with the amphotericin-perfo-
rated patch-clamp technique using an Axopatch 200B amplifier 
(Molecular Devices Corporation, Sunnyvale, CA, USA). Data 
acquisition and analysis were accomplished using custom soft-
ware. Signals were low-pass filtered with a cut-off frequency of 
5 kHz and digitized at 10 kHz. Potentials were corrected for the 
estimated liquid junction potential. Patch pipettes (borosilicate 
glass; resistance ≈2.0 MΩ) contained (in mmol/l): K-gluconate 
125, KCl 20, NaCl 5, amphotericin-B 0.22, HEPES 10, pH 7.2 
(KOH).
Action potentials (APs) were elicited at 0.5–4 Hz by 3-ms, 
1.5 times diastolic threshold current pulses through the patch 
pipette. We analyzed resting membrane potential (RMP), pla-
teau potential (Pla) measured 100 ms after the AP upstroke, and 







, respectively). Data from 10 consecutive APs 
were averaged.
Action Potentials were measured in the absence and presence of 
a clinically relevant mixture of fish oil fatty acids EPA (8 μmol/l) 
and DHA (7 μmol/l) (Den Ruijter et al., 2008) or in the absence 
and presence of the control fatty acid oleic acid (OA; 15 μmol/l). 
OA (Sigma), DHA (Sigma), and EPA (Sigma) were prepared as 
10 mmol/l stock solutions in dimethyl sulfoxide, stored under nitro-
gen at –20°C, and diluted appropriately 20 min before use. In order 
to obtain steady-state conditions, AP recordings were started 5 min 
after application of the various fatty acids.
Table 1 | Phospholipid composition of the heart (% of total fat extracted) 
and plasma free fatty acid concentrations.
 ω3 diet (N = 5) ω9 diet (N = 3)
PHOSPHOlIPIDS FROM vENTRICUlAR HEART TISSUE (% OF TOTAl
FAT ExTRACTED)
Saturated fatty acids 29 (0.8) 29 (2.4)
Mono-unsaturated fatty acids 22 (2.0)* 31 (3.4)
Polyunsaturated fatty acids 47 (2.7) 38 (4.9)
Sum of ω3 fatty acids 14 (1.8)* 5 (0.1)
EPA 3.4 (0.9)* 0.1 (0.0)
DHA 4.7 (1.3)* 0.3 (0.2)
Sum of ω6 fatty acids 33 (1.1) 33 (5.1)
Unknown 1 (0.2) 1 (0.5)
PlASMA FREE FATTy ACIDS (μMOl/l)
EPA 7.8 (1.01)* 3.1 (0.73)
DHA 5.9 (1.31) 4.6 (0.52)
EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. *P < 0.05 compared 
to ω9 sunflower oil.
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Figures 2A,D show typical action potentials at 1 Hz recorded 
from an ω9 and an ω3 myocyte, respectively, in the absence 
and presence of the mixture of EPA + DHA. In the ω9 myocyte 
(Figure 2A), but not in the ω3 myocytes (Figure 2D), EPA + DHA 
shortened the action potential. Figures 2B,E summarize the effects 
of EPA + DHA on the APD
90
 in ω9 and ω3 myocytes, respectively. 
On average, ω9 myocytes have a 20% decreased APD
90
 in presence 
of EPA + DHA. In ω9 myocytes, the action potential shorten-
ing due to application of EPA + DHA was present at low pacing 
frequencies (Figure 2C). The control fatty acid OA did neither 
affect the action potential duration in ω9, nor in ω9 myocytes 
(Figures 2C,F).
disCussion
The action potentials measured in isolated myocytes of the ω3 
fed rabbits were approximately 20% shorter compared to the ω9 
fed rabbits. Interestingly, the application of a mixture of physi-
ological relevant concentrations of EPA + DHA resulted in a 
similar shortening of the action potential by approximately 20% 
in ω9 myocytes. The action potentials recorded from the ω3 fed 
rabbits were not shortened by acute application of EPA + DHA. 
These data indicate that it does not matter whether ω3-PUFAs 
are incorporated in the sarcolemma following a previous diet or 
are administered acutely with respect to their effects on action 
potentials. This is surprising because the effects of incorporated 
or acutely administered ω3-PUFAs on ionic currents are dif-
ferent, despite the similarity of the effects on action potential 
duration. For example, acute application of ω3-PUFAs in ferret 
cardiomyocytes does not change I
K1
 (Xiao et al., 2002), whereas 
incorporation of ω3-PUFAs following a fish oil diet increases I
K1
 
by approximately 50% in porcine ventricular myocytes (Verkerk 
et al., 2006).Thus, although the mechanism may be different, both 
acute and incorporated ω3-PUFAs shorten the cardiac action 
potential duration of many species (Kang, 1995; Macleod et al., 
1998; Ander et al., 2004).
The lack of shortening of EPA + DHA in the ω3 group implies 
that saturation of the membrane with ω3-PUFAs in the ω3 myo-
cytes prevents further shortening of the cardiac action potential. 
This suggests that the mechanism for the cardiac action potential 
shortening in the ω9 group is not the result of a direct ligand-like 
interaction with the ion channels per se, but rather that it depends 
on membrane composition. However, Xiao et al. (2001) showed 
that substitution of a single amino acid in the hH1α unit of the fast 
sodium current (I
Na
) reduced the inhibitory effect of EPA on the 
current amplitude, suggesting direct interference between the fatty 
acid and the ion channel. However, other ligand gated ion channels 
that lack amino acid homology with voltage gated ion channel are 
also inhibited by acute administration of ω3-PUFAs (Leaf et al., 
2002). Therefore, it has been suggested that fatty acids primarily 
alter membrane composition close to ion channels rather than that 
they directly interact with the ion channel protein (Lundbaek and 
Andersen, 1999). The incorporation of the long acyl chain of the 
fatty acid may compress the phospholipid bilayer resulting in a mis-
match with the hydrophobic length of the transmembrane channel 
(Girshman et al., 1997). Compression or stretch by the long-chain 
fatty acids may alter the conformational state and conductance of 
ion channels (Lundbaek and Andersen, 1999).
inCorporated Fish oil shortens the CardiaC aCtion potential
Figure 1A shows representative action potentials at 1 Hz from a 
myocyte isolated from a ω3 and a ω9 heart in the absence of fatty 
acids. The ω3 action potential has a more negative plateau poten-
tial (Pla) and is considerably shorter than the ω9 action potential. 
Figure 1B summarizes the action potential characteristics of the 
ω3 and ω9 myocytes. On average, ω3 myocytes show a 60% more 
negative plateau potential and a 20% shorter action potential at 90% 
repolarization. No significant differences in RMP were observed. The 
AP shortening in ω3 myocytes is evident at 0.5–3 Hz (Figure 1C).
aCutely adMinistered Fish oil Fatty aCids do not shorten the 
CardiaC aCtion potential in isolated MyoCytes oF Fish oil 
Fed rabbits
To determine the effect of circulating ω3 fatty acids, we superfused 
myocytes of both groups with either a mixture of free EPA and DHA 
(combined 15 μM), or used the control fatty acid OA (15 μM). The 
concentration of fish oil fatty acids was based on the free fatty acid 
analysis of the plasma of the rabbits (Table 1).
Figure 1 | (A) Typical examples of action potentials recorded at 1 Hz from 
isolated myocytes of a rabbit fed a ω3 diet and an ω9 diet. (B) Average action 
potential characteristics of ω3 and ω9 myocytes at 1 Hz. APD20, APD50, and 
APD90, AP duration at 20, 50, and 90% repolarization; RMP, resting membrane 
potential; Pla, Plateau amplitude measured 100 ms following upstroke, 
*P < 0.05 in unpaired t-test. (C) Stimulus frequency-dependency of APD90 in 
ω3 and ω9 myocytes.
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unknown. Therefore, we measured free fatty acid levels of EPA and 
DHA in plasma samples of the SOFA trial (Brouwer et al., 2006; 
Den Ruijter et al., 2008). This trial included patients who were tak-
ing fish oil-2g/day for a median of 365 days. Their free ω3-PUFAs 
were in the range of 5.0–16.4 μmol/l. The rabbits in our study had 
free EPA and DHA levels comparable to those seen in fish oil sup-
plemented patients (Table 1).
Harris et al. (2004) have reported EPA and DHA levels in 
human cardiac tissue up to 2.5% of total fatty acids (Harris et al., 
2004). Billman et al. (2010) reported a strong dose-dependent 
effect of fish oil intake (from 1 to 4 g/day) on cardiac ome-
ga-3 index (from 4 to 7%) in dogs. Also in humans, the cardiac 
 omega-3 status can be modified. Moreover, several research 
groups advocate the use of the omega-3 red blood cells (the 
omega-3 index) as a measure of a person’s cardiac omega-3 status 
The effect of acute free ω3-PUFAs in our study occurs within 
minutes, an observation that suggests a rapid uptake into the 
outer leaflet of the membrane in a protein-independent manner. 
Long-term exposure to ω3-PUFAs may involve membrane fatty 
acid transporters resulting in esterification into phospholipids (see 
for review Glatz et al., 2010) and diffusion to specific domains. 
Here, ω3-PUFAs may indeed alter many basic properties of cardiac 
membranes (Stillwell and Wassall, 2003). Apparently, the acute and 
long-term exposures of ω3-PUFAs to the cardiac membrane, likely 
through different processes, influence each other.
Data on plasma levels of ω3-PUFAs following dietary interven-
tions are limited. Fish oil supplements (2 g EPA and 1.4 g DHA) for 
5 weeks in menopausal woman resulted in an increase in plasma 
EPA and DHA up to 0.5–0.7 mmol/l (Higdon et al., 2000). To which 
extent these fatty acids are “free” to enter the interstitial space is 
Figure 2 | (A,D) Typical example of a action potential recorded from a isolated 
myocytes of a rabbit fed a ω9 (A) or ω3 (D) diet in the absence and presence of 
EPA + DHA (15 μM in total). (C,D) Averaged data on APD90 in the ω9 (B) and ω3 
(e) group before and after 5 min of superfusion with EPA + DHA. Superfusion 
with EPA/DHA resulted in a significant shortening of the APD90 in the ω9, but not 
in the ω3 group. Average data on the relative change induced by the acute 
superfusion of EPA + DHA and control fatty acid OA in the ω9 (C) and ω3 (F) 
group.
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(Harris et al., 2004; von Schacky and Harris, 2007). Although we 
did not measure effects in vivo, our data suggest that patients 
with a high cardiac omega-3 status should maintain their status 
by continuation of their life style. They may not benefit from a 
high(er) dose of fish oil supplementation as a kind of prophy-
lactic antiarrhythmic therapy.
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